Cilcare
Description
Cilcare is a Biotech harnessing auditory sciences for the early detection and treatment of cochlear synaptopathy.
Cilcare’s core mission is to forge partnerships to develop groundbreaking solutions for individuals grappling with hearing disorders, considering hearing being not only the capacity to hear or understand speech but an entry point to global health that can play a key role in the era of a medicine increasingly integrating prevention in its fundamentals.
With its operational hubs strategically located in Montpellier, Paris, and Boston, the company has swiftly ascended to a leadership position on the global stage in the field of hearing science, exhibiting unique expertise in the preclinical and clinical evaluation of therapies for hearing.
Company members
Celia BELLINE
